Click' Login' then 'Don't have an Account ' and join $$Lounge for free

Lexaria Corp CSE:LXX OTC:LXRP

More
2 months 1 week ago #120466 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
GB, I agree

The Globe and Mail reports in its Thursday edition that analyst recommendations on weed stocks have been "laughably inaccurate." The Globe's David Berman writes that he looked at 26 analyst recommendations by five brokerages for six marijuana stocks, which is a wide sample of the overall coverage of the marijuana sector. He graded the results based on whether the calls made money, lost money, missed rallies or avoided declines. Nearly half of the calls (12 of 26) received letter grades of C or lower, meaning that the call either lost money or missed rallies. This dismal performance implies that analyst recommendations are not providing much assistance. Canada's pot sector is striving for acceptance by sophisticated long-term investors, and coverage by financial analysts is a step toward respectability. The weed sector has attracted analysis by Cormark Securities, Beacon Securities, Echelon Wealth Partners, GMP Securities and Canaccord Genuity. This week, BMO Nesbitt Burns became the first bank-owned brokerage to begin covering the marijuana sector. Mr. Berman says given the overall inaccuracy of recommendations, it is nearly impossible for investors to know which opinion to follow, on which stock, and when.

They should be listening to Struthers and would have made a killing on LXX and CBW, his recent call for LXX to $1.05 was very good. Hope it does not go lower

Please Log in or Create an account to join the conversation.

More
2 months 1 week ago #120465 by GoldnBoy
GoldnBoy replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
The LCBO said that the first Ontario Cannabis Store locations will be in Guelph, Kingston, Toronto and Thunder Bay. Just 4 locations, bet there will be massive line ups. I would think many will continue through current medical channels.

The lineups should make good headlines lol

Please Log in or Create an account to join the conversation.

More
2 months 1 week ago #120456 by RonS
RonS replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
TORONTO, April 9, 2018

HMMJ remains the world's largest Marijuana ETF

TORONTO, April 9, 2018 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") is proud to announce that the Horizons Marijuana Life Sciences Index ETF ("HMMJ") has reached its one-year anniversary. HMMJ generated a one-year return for the period ending April 4, 2018, of 58.6% – making it the best-performing Canadian-listed ETF during this timeframe.

Since its inception on April 4, 2017, HMMJ – the world's first and largest Marijuana ETF – has brought in significant assets under management ("AUM"). Its AUM peaked at approximately $863 million on January 23, 2018 before market pull-backs. Its AUM now stands at over $622 million (as at April 6, 2018).

Please Log in or Create an account to join the conversation.

More
2 months 1 week ago #120449 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
The Globe and Mail reports in its Monday edition that TD Bank is limiting the ways in which its advisers discuss the industry with clients, banning staff from recommending almost all marijuana firms and exchange-traded funds (ETFs). The Globe's Clare O'Hara and Christina Pellegrini write that TD is also prohibiting portfolio managers from pro-actively adding most cannabis shares to client investment accounts -- unless clients specifically instruct their adviser to do so. As a result, TD Wealth Private Investment Advice has put dozens of pot stocks and the four cannabis ETFs onto its non-approved list of securities, leaving advisers with only three Canadian marijuana stocks to suggest. As of Friday, TD advisers were approved to recommend the country's largest publicly traded producer of the drug, Canopy Growth, and two smaller, growers called Emerald Health Therapeutics and Emblem. The restrictions put on advisers who work at PIA appear to be driven out of concern of the legal risks the bank could face in the United States, where cannabis is legal in some states but illegal under federal law. The TD policy includes companies with no U.S. operations; it is not clear why those companies are included.

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120442 by GoldnBoy
GoldnBoy replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Great rebound in the stock. I added a bit on the dip as well

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120437 by JunglistGuy
JunglistGuy replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Yes, nice call. I bought some at $1.10

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120436 by alexgreat
alexgreat replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Looks like another nice call by Struthers to buy on weakness around $1.05. Thankyou Sir, nice bounce of that today

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120434 by alexgreat
alexgreat replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Stock came down to $1.05 area Ron highlighted. Added some stock there so hope we seen the bottom. Markets have seen quite a correction

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120428 by WealthyPlumber
WealthyPlumber replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Check out chart of the day, Ron has interesting sentiment chart compared to Canopy Growth WEED
www.playstocks.net/index.php/market-trends/chart-of-the-day

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120424 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Lexaria Expands into Transdermal, Grows Licensing Revenue -- CFN Media

SEATTLE, April 04, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Lexaria Bioscience Corp.’s (CSE:LXX) (LXX.CN) (CNSX:LXX) (OTCQB:LXRP) DehydraTECH™ which represents a breakthrough in cannabinoid drug delivery. Lexaria’s DehydraTECH™ is technology that promotes a molecular association between cannabinoids and certain fatty acid compounds that are known to have palatability and bio-absorption enhancing properties. This combination, in turn, results in improved cannabinoid taste, bioavailability and speed of effectiveness.

In the quickly expanding legal cannabis industry, effective delivery of the drug is an ongoing problem. Many consumers have taken to edible products as a healthier alternative to smoking, but there are still key issues with bioavailability and taste when infusing cannabinoids. Other delivery methods have gained in popularity as well, including topical creams and lotions. In addition to improving intestinal bio-absorption by as much as five to ten times in as little as 15 minutes, new laboratory study data has shown that the DehydraTECH™ technology is just as promising when it comes to transdermal applications.

Transdermal Applications

In March, the company announced the results from its first laboratory study of DehydraTECH™ on human skin at a California-based laboratory specializing in Franz diffusion cell skin permeability testing. Researchers compared the technology with two leading skin penetration enhancers, looking for penetration time, absorption quantity, and peak amounts of CBD absorbed into and through the skin at multiple testing intervals over 48 hours.

The researchers found that DehydraTECH™ was the fastest acting for absorption into the skin and demonstrated the highest overall average quantity of CBD delivered through the skin. In fact, the technology outperformed competing products by as much as 225%. The technology also lacked any odor, even without the use of perfumes, contrary to other cannabinoid industry products that can be quite odoriferous without the use of masking perfumes.

“We have theorized for some time that our DehydraTECH™ delivery system might have positive effects on skin-based delivery complementing its already commercialized gastro-intestinal product applications,” said Lexaria President John Docherty. “The first round of testing was very encouraging and showed clear benefits with regards to speed of action and, particularly, delivery of CBD across the skin barrier for potential transdermal applications.”

Building an IP Portfolio

Lexaria has already begun to commercialize the DehydraTECH™ delivery system, as well as build up its patent portfolio. Earlier this year, the company entered into two licensing agreements for the innovative platform with a cannabis edibles maker and a Canadian cannabis chocolate manufacturer. Under these agreements, the company has licensed out its technology for the development of edible products in exchange for licensing fees and royalties.

On March 22, the company announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office providing for a “composition of matter” claims that protect the specific combination of substances which enable improved taste and bio-absorption. This adds to the company’s existing “method of use” patent that had previously been granted, further protects its delivery system, and opens the door to further commercialization.

“This Notice of Allowance applies to the delivery of both psychoactive and non-psychoactive cannabinoids as lipophilic active agents formulated together with the edible fatty acids that enable the powerful bioavailability and taste enhancing properties of the DehydraTECH™ technology,” said Mr. Docherty. “This allowance has been granted by the USPTO upon review of the compelling scientific data Lexaria has amassed.”

Looking Ahead

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP) represents a compelling investment opportunity in the cannabis industry. By solving a key issue facing many edibles manufacturers, the company hopes to license its technology to a growing number of companies in exchange for licensing fees and royalties. These high-margin revenues could unlock significant value for shareholders over the long-term.

For more information, visit the company’s website or download their investor presentation.

Please follow the link to read the full article: www.cannabisfn.com/lexaria-expands-trans...s-licensing-revenue/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: www.cannabisfn.com

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120402 by JunglistGuy
JunglistGuy replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Maybe a good buy, I think the sector will see another good rally ahead of summer legalization

Please Log in or Create an account to join the conversation.

More
2 months 2 weeks ago #120401 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Easter Bunny delivered an explosive egg. Markets getting hammered today and LXX among others going down with it

Please Log in or Create an account to join the conversation.

Time to create page: 0.194 seconds

Login Form